422 related articles for article (PubMed ID: 30902857)
1. Microcin PDI Inhibits Antibiotic-Resistant Strains of Escherichia coli and
Lu SY; Graça T; Avillan JJ; Zhao Z; Call DR
Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30902857
[TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Screening Identifies Six Genes That Are Associated with Susceptibility to Escherichia coli Microcin PDI.
Zhao Z; Eberhart LJ; Orfe LH; Lu SY; Besser TE; Call DR
Appl Environ Microbiol; 2015 Oct; 81(20):6953-63. PubMed ID: 26209678
[TBL] [Abstract][Full Text] [Related]
3. Microcin PDI regulation and proteolytic cleavage are unique among known microcins.
Zhao Z; Orfe LH; Liu J; Lu SY; Besser TE; Call DR
Sci Rep; 2017 Feb; 7():42529. PubMed ID: 28205647
[TBL] [Abstract][Full Text] [Related]
4. Colicin V38 and microcin C38 produced by Escherichia coli strain 38.
Leavitt RW; Braithwaite C; Jensen MM
Avian Dis; 1997; 41(3):568-77. PubMed ID: 9356701
[TBL] [Abstract][Full Text] [Related]
5. Microcin MccPDI reduces the prevalence of susceptible Escherichia coli in neonatal calves.
Eberhart LJ; Ochoa JN; Besser TE; Call DR
J Appl Microbiol; 2014 Aug; 117(2):340-6. PubMed ID: 24797067
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel microcin that kills enterohemorrhagic Escherichia coli O157:H7 and O26.
Eberhart LJ; Deringer JR; Brayton KA; Sawant AA; Besser TE; Call DR
Appl Environ Microbiol; 2012 Sep; 78(18):6592-9. PubMed ID: 22773653
[TBL] [Abstract][Full Text] [Related]
7. Activity spectrum of colicins produced by Shigella sonnei and genetic mechanism of colicin resistance in conspecific S. sonnei strains and Escherichia coli.
Calcuttawala F; Hariharan C; Pazhani GP; Ghosh S; Ramamurthy T
Antimicrob Agents Chemother; 2015 Jan; 59(1):152-8. PubMed ID: 25331695
[TBL] [Abstract][Full Text] [Related]
8. Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.
Budič M; Rijavec M; Petkovšek Z; Zgur-Bertok D
PLoS One; 2011; 6(12):e28769. PubMed ID: 22205967
[TBL] [Abstract][Full Text] [Related]
9. Microcin E492, a low-molecular-weight peptide antibiotic which causes depolarization of the Escherichia coli cytoplasmic membrane.
de Lorenzo V; Pugsley AP
Antimicrob Agents Chemother; 1985 Apr; 27(4):666-9. PubMed ID: 2408563
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Potential and Synergetic Effects of Microcins against Multidrug-Resistant
Telhig S; Ben Said L; Torres C; Rebuffat S; Zirah S; Fliss I
Microbiol Spectr; 2022 Jun; 10(3):e0275221. PubMed ID: 35543514
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli outer membrane protein TolC is involved in production of the peptide antibiotic microcin J25.
Delgado MA; Solbiati JO; Chiuchiolo MJ; Farías RN; Salomón RA
J Bacteriol; 1999 Mar; 181(6):1968-70. PubMed ID: 10074099
[TBL] [Abstract][Full Text] [Related]
12. Non-antibiotic antibacterial peptides and proteins of
Bosák J; Hrala M; Micenková L; Šmajs D
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):309-322. PubMed ID: 32856960
[TBL] [Abstract][Full Text] [Related]
13. Colicins U and Y inhibit growth of Escherichia coli strains via recognition of conserved OmpA extracellular loop 1.
Bosák J; Micenková L; Doležalová M; Šmajs D
Int J Med Microbiol; 2016 Nov; 306(7):486-494. PubMed ID: 27510856
[TBL] [Abstract][Full Text] [Related]
14. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
[TBL] [Abstract][Full Text] [Related]
15. Colicin-Mediated Transport of DNA through the Iron Transporter FepA.
Cohen-Khait R; Harmalkar A; Pham P; Webby MN; Housden NG; Elliston E; Hopper JTS; Mohammed S; Robinson CV; Gray JJ; Kleanthous C
mBio; 2021 Oct; 12(5):e0178721. PubMed ID: 34544275
[TBL] [Abstract][Full Text] [Related]
16. Exploring the genetic basis of natural resistance to microcins.
Telhig S; Pham NP; Ben Said L; Rebuffat S; Ouellette M; Zirah S; Fliss I
Microb Genom; 2024 Feb; 10(2):. PubMed ID: 38407259
[No Abstract] [Full Text] [Related]
17. The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN.
Patzer SI; Baquero MR; Bravo D; Moreno F; Hantke K
Microbiology (Reading); 2003 Sep; 149(Pt 9):2557-2570. PubMed ID: 12949180
[TBL] [Abstract][Full Text] [Related]
18. Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model.
Tängdén T; Adler M; Cars O; Sandegren L; Löwdin E
J Antimicrob Chemother; 2013 Jun; 68(6):1319-26. PubMed ID: 23478794
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of Escherichia coli strains producing microcins of B and C types.
Khmel IA; Bondarenko VM; Manokhina IM; Basyuk EI; Metlitskaya AZ; Lipasova VA; Romanova YM
FEMS Microbiol Lett; 1993 Aug; 111(2-3):269-74. PubMed ID: 8405936
[TBL] [Abstract][Full Text] [Related]
20. Natural antibiotic susceptibility of Escherichia coli, Shigella, E. vulneris, and E. hermannii strains.
Stock I; Wiedemann B
Diagn Microbiol Infect Dis; 1999 Mar; 33(3):187-99. PubMed ID: 10092968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
